abstract |
Provided are specific antibodies against T-cell immune response cDNA7 TIRC7 costimulatory molecule, which are capable of inhibiting proliferation of peripheral blood mononuclear cells PBMCs. In particular, high affinity monoclonal and chimeric antiĀTIRC7 antibodies are described. Compositions comprising such antibodies and their use for the treatment of immune diseases are provided. |